Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by <i>in vivo</i> RNAi targeting <i>Cyp2e1</i>.

"Conflicts of interest The authors declare no conflicts of interest."

"This work is kindly supported by The National Key R&D Program of China: Chinese-Australian ‘Belt and Road’ Joint Laboratory on Traditional Chinese Medicine for the Prevention and Treatment of Severe Infectious Diseases (2020YFE0205100, China), Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources (2060302, China), Zhenjiang social development project (SH2020036, China), National Key R&D Program of China (2019YFA0802801 and 2018YFA0801401, China), the 10.13039/501100001809National Natural Science Foundation of China (31871345 and 32071442, China), Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (TFJC2018004, China), the 10.13039/501100012226Fundamental Research Funds for the Central Universities (China), the Non-profit Central Research Institute Fund of 10.13039/501100005150Chinese Academy of Medical Sciences (2020-PT320-004, China), Applied Basic Frontier Program of Wuhan City (2020020601012216, China), Hubei Health Commission Young Investigator award (China) and startup funding from 10.13039/501100007046Wuhan University (China). We appreciate the helpful discussion and great technical support from Professor Song Shen from School of Pharmacy of Jiangsu University (Zhenjiang, China)."